PT - JOURNAL ARTICLE AU - Barría-Sandoval, Claudia AU - Mendez, Angie AU - Ferreira, Guillermo AU - Toffoletto, María Cecilia TI - Impact of COVID-19 on deaths from respiratory diseases: Panel Data evidence from Chile AID - 10.1101/2021.06.20.21259216 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.20.21259216 4099 - http://medrxiv.org/content/early/2021/06/25/2021.06.20.21259216.short 4100 - http://medrxiv.org/content/early/2021/06/25/2021.06.20.21259216.full AB - The COVID-19 pandemic has left other pathologies commonly present in the population in a secondary context. Therefore, it is necessary to study the evolution of these diseases in the presence or absence of COVID-19.Objectives The present study had the following objectives: 1. To evaluate the relationship between the COVID-19 epidemic and the possible decrease in deaths from respiratory diseases in Chile. 2 Study the relationship between meteorological variables and severity of COVID-19 with respect to deaths from respiratory diseases from January 2018 to February 2021.Methods The variable number of deaths due to respiratory diseases in Chile was analyzed considering the monthly records of meteorological variables (temperature, precipitation and humidity) in each Region of Chile and severity of COVID-19, to evaluate the mortality trend before and after the pandemic. For this, different Non-Observable Heterogeneity Models for Panel Data were usedResults Our findings show that among the variables that affect the mortality rate from respiratory diseases, there are the number of deaths from COVID-19 that has a negative effect, the number of patients with COVID-19 in intensive care unit (ICU) that has a positive effect and the minimum temperature with a negative effect. These results are supported by the application of the panel regression with one-way random-effects models.Conclusion This study revealed that there is an unexpected reduction in deaths from respiratory diseases in Chile in the post-pandemic period. Therefore, it can be concluded that this variable decreased with the appearance of the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo competing interestsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No competing interestsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThese variables 127 include the data on the number of deaths from respiratory diseases obtained from the 128 Ministry of Health https://deis.minsal.cl/, whereas the data on the variables 129 regarding the severity of COVId-19 were obtained from the Ministry of Science and 130 Technology https://www.minciencia.gob.cl/covid19. Finally, the data of the 131 temperature and precipitation variables were obtained from the updated report of the 132 Chilean Meteorological Directorate DGAC, which are available on the website 133 https://climatologia.meteochile.gob.cl.